| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 2.65B | 2.47B | 2.18B | 2.49B | 2.34B |
| Gross Profit | 521.55M | 486.22M | 417.78M | 477.62M | 447.61M |
| EBITDA | 355.24M | 300.88M | 248.03M | 295.71M | 260.81M |
| Net Income | 224.99M | 200.50M | 163.48M | 172.73M | 163.11M |
Balance Sheet | |||||
| Total Assets | 2.18B | 2.25B | 1.97B | 1.89B | 1.96B |
| Cash, Cash Equivalents and Short-Term Investments | 382.26M | 573.46M | 607.14M | 455.06M | 401.27M |
| Total Debt | 39.93M | 174.70M | 89.89M | 132.52M | 198.43M |
| Total Liabilities | 573.21M | 719.01M | 535.66M | 549.67M | 666.18M |
| Stockholders Equity | 1.61B | 1.53B | 1.43B | 1.34B | 1.29B |
Cash Flow | |||||
| Free Cash Flow | 123.74M | -3.25M | 269.05M | 257.40M | 124.46M |
| Operating Cash Flow | 270.19M | 105.54M | 312.97M | 349.15M | 189.86M |
| Investing Cash Flow | 1.97M | -167.93M | -88.42M | -135.48M | -84.99M |
| Financing Cash Flow | -315.96M | -53.85M | -134.74M | -144.58M | -93.71M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | HK$4.61B | 7.36 | 10.39% | 8.21% | 11.68% | 9.03% | |
78 Outperform | HK$50.32B | 10.31 | 21.66% | 6.15% | 5.52% | 3.94% | |
73 Outperform | HK$18.71B | 10.91 | 14.30% | 5.87% | 6.88% | 11.98% | |
71 Outperform | HK$72.67B | 14.56 | 17.82% | 4.31% | 8.19% | -6.72% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
59 Neutral | HK$1.58B | 6.53 | 4.73% | 8.06% | -2.44% | -5.98% | |
57 Neutral | HK$10.34B | 15.15 | 7.16% | ― | -12.54% | -13.99% |